CAR-T cell therapy shows promise in child’s neuroblastoma
IMAGE: GETTY royalty free Labtech.eu reported on 1 May that Cell Medica, London-based biotech, has reported early data from a clinical trial that resulted in 'extensive tumour regression' in a